These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 37765293)
1. Dynamic Ex Vivo Porcine Eye Model to Measure Ophthalmic Drug Penetration under Simulated Lacrimal Flow. Barbalho GN; Falcão MA; Lopes JMS; Lopes JM; Contarato JLA; Gelfuso GM; Cunha-Filho M; Gratieri T Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765293 [TBL] [Abstract][Full Text] [Related]
2. OphthalMimic: A new alternative apparatus without animal tissue for the evaluation of topical ophthalmic drug products. Barbalho GN; Falcão MA; Alves Amaral V; Contarato JLA; Barbalho AM; Kaori Diógenes G; Mariana Gomes Silva M; Carvalho de Barros do Vale Rochelle B; Gelfuso GM; Cunha-Filho M; Gratieri T Methods; 2024 Aug; 228():1-11. PubMed ID: 38759909 [TBL] [Abstract][Full Text] [Related]
3. De Hoon I; Boukherroub R; De Smedt SC; Szunerits S; Sauvage F Mol Pharm; 2023 Jul; 20(7):3298-3319. PubMed ID: 37314950 [TBL] [Abstract][Full Text] [Related]
4. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel. Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994 [TBL] [Abstract][Full Text] [Related]
5. Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models. Juretić M; Cetina-Čižmek B; Filipović-Grčić J; Hafner A; Lovrić J; Pepić I Eur J Pharm Sci; 2018 Jul; 120():133-141. PubMed ID: 29702232 [TBL] [Abstract][Full Text] [Related]
6. Applying Different Conditions in the OphthalMimic Device Using Polymeric and Hydrogel-Based Hybrid Membranes to Evaluate Gels and Nanostructured Ophthalmic Formulations. Contarato JLA; Barbalho GN; Cunha-Filho M; Gelfuso GM; Gratieri T Gels; 2024 Aug; 10(8):. PubMed ID: 39195067 [TBL] [Abstract][Full Text] [Related]
7. Rapid assessment of ocular drug delivery in a novel ex vivo corneal model. Begum G; Leigh T; Courtie E; Moakes R; Butt G; Ahmed Z; Rauz S; Logan A; Blanch RJ Sci Rep; 2020 Jul; 10(1):11754. PubMed ID: 32678110 [TBL] [Abstract][Full Text] [Related]
8. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies. Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418 [TBL] [Abstract][Full Text] [Related]
9. Mucoadhesive phenylboronic acid conjugated chitosan oligosaccharide-vitamin E copolymer for topical ocular delivery of voriconazole: Synthesis, in vitro/vivo evaluation, and mechanism. Sun X; Sheng Y; Li K; Sai S; Feng J; Li Y; Zhang J; Han J; Tian B Acta Biomater; 2022 Jan; 138():193-207. PubMed ID: 34757228 [TBL] [Abstract][Full Text] [Related]
10. Thermoresponsive ophthalmic poloxamer/tween/carbopol in situ gels of a poorly water-soluble drug fluconazole: preparation and in vitro-in vivo evaluation. Lihong W; Xin C; Yongxue G; Yiying B; Gang C Drug Dev Ind Pharm; 2014 Oct; 40(10):1402-10. PubMed ID: 23944837 [TBL] [Abstract][Full Text] [Related]
12. New Approach in Ocular Drug Delivery: In vitro and ex vivo Investigation of Cyclodextrin-Containing, Mucoadhesive Eye Drop Formulations. Bíró T; Bocsik A; Jurišić Dukovski B; Gróf I; Lovrić J; Csóka I; Deli MA; Aigner Z Drug Des Devel Ther; 2021; 15():351-360. PubMed ID: 33568896 [TBL] [Abstract][Full Text] [Related]
13. Effect of hydroxypropyl-β-cyclodextrin on the ocular bioavailability of dexamethasone from a pH-induced mucoadhesive hydrogel. Kesavan K; Kant S; Singh PN; Pandit JK Curr Eye Res; 2011 Oct; 36(10):918-29. PubMed ID: 21950697 [TBL] [Abstract][Full Text] [Related]
14. Prospective insulin-based ophthalmic delivery systems for the treatment of dry eye syndrome and corneal injuries. Cruz-Cazarim ELC; Cazarim MS; Ogunjimi AT; Petrilli R; Rocha EM; Lopez RFV Eur J Pharm Biopharm; 2019 Jul; 140():1-10. PubMed ID: 31015020 [TBL] [Abstract][Full Text] [Related]
16. In vitro and ex vivo correlation of drug release from ophthalmic ointments. Bao Q; Newman B; Wang Y; Choi S; Burgess DJ J Control Release; 2018 Apr; 276():93-101. PubMed ID: 29518465 [TBL] [Abstract][Full Text] [Related]
17. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular. Li J; Tan G; Cheng B; Liu D; Pan W Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370 [TBL] [Abstract][Full Text] [Related]
18. Development of an ex vivo method for evaluation of precorneal residence of topical ophthalmic formulations. Liu Q; Wang Y AAPS PharmSciTech; 2009; 10(3):796-805. PubMed ID: 19521781 [TBL] [Abstract][Full Text] [Related]
19. In vitro and ex vivo corneal penetration and absorption models. Agarwal P; Rupenthal ID Drug Deliv Transl Res; 2016 Dec; 6(6):634-647. PubMed ID: 26762419 [TBL] [Abstract][Full Text] [Related]
20. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept. Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]